Medicated Skin Care in Italy

July 2012 | 45 pages | ID: M0AF9945924EN
Euromonitor International Ltd

Abstracts

2011 STRONG GROWTH RATES IN MEDICATED SKIN CARE CLEARLY WITNESSES HOW ITALIANS ARE BECOMING AWARE OF THE RISK RELATED TO A BAD CARE OF THEIR SKIN. MEDIA’S CAMPAIGNS AIMED TO INCREASE PEOPLE’S AWARENESS TOWARDS THE RISK OF SUN UNPROTECTED EXPOSURE, SHARING COMMUNAL SPACES, OR USING GENERIC PRODUCTS FOR EXAMPLE, HAVE BEEN VERY EFFECTIVE.


Euromonitor International's Medicated Skin Care in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Medicated Skin Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

MEDICATED SKIN CARE IN ITALY
Euromonitor International
July 2012

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
A Menarini Industrie Farmaceutiche Riunite SRL in Consumer Health (italy)
Strategic Direction
Key Facts
  Summary 1 A Menarini Industrie Farmaceutiche Riunite Srl: Key Facts
  Summary 2 A Menarini Industrie Farmaceutiche Riunite Srl: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 3 A Menarini Industrie Farmaceutiche Riunite Srl: Competitive Position 2011
Bayer SpA in Consumer Health (italy)
Strategic Direction
Key Facts
  Summary 4 Bayer SpA: Key Facts
  Summary 5 Bayer SpA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 6 Bayer SpA: Competitive Position 2011
Bracco SpA in Consumer Health (italy)
Strategic Direction
Key Facts
  Summary 7 Bracco SpA: Key Facts
  Summary 8 Bracco SpA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 9 Bracco SpA: Competitive Position 2011
Recordati Industria Chimica E Farmaceutica SpA in Consumer Health (italy)
Strategic Direction
Key Facts
  Summary 10 Recordati Industria Chimica e Farmaceutica SpA: Key Facts
  Summary 11 Recordati Industria Chimica e Farmaceutica SpA: Operational Indicators
Company Background
Production
  Summary 12 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics
Competitive Positioning
  Summary 13 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2011
Sanofi-aventis SpA in Consumer Health (italy)
Strategic Direction
Key Facts
  Summary 14 Sanofi-Aventis SpA: Key Facts
  Summary 15 Sanofi-Aventis SpA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 16 Sanofi-Aventis SpA: Competitive Position 2011
Executive Summary
Task-specific and New Products Led Growth
Consumer Health Is Increasingly Fragmented
Health and Beauty Retailers Keep the Lion's Share
Consumer Health Will Post Further Growth Over Forecast Period
Key Trends and Developments
Increasing Awareness of Prevention - Health and Beauty
Poor Economy Has A Varied Impact on OTC Products and Dietary Supplements
Consumers Still Lack Trust in Generics, But Private Label Develops Slowly
Chemists/pharmacies Is Still the Cornerstone of Distribution
Increasing Interest in Herbal/traditional Products and Organic Ingredients
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
Non-prescription Medicines: Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine Impacting Consumer Health
Switches
  Summary 17 OTC - Switches 2010-2011
Definitions
Sources
  Summary 18 Research Sources